Data Monitoring Committees (DMCs) in Clinical Research - Its Effect on Subject Public Safety and How can it be Effectively Set up

Instructor: Charles H Pierce
Product ID: 701633
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

In this Data Monitoring Committees (DMCs) training for Clinical Research learn why the increase in using Data Monitoring Committees (DMCs) in Clinical Research affects Subject-public Safety: How they are set up to be effective?

Why Should You Attend:

Data Monitoring Committees (DMCs, DSMBs) are increasingly seen as an integral part of multi centered trials. They are set-up by the sponsors of the research but impact every level of the process. Safety monitoring is mandated throughout the regulations (21 CFR 312.50, 312.56, and 600.80 for drugs and biologics and 21 CFR 812.40 and 812.46 for devices) and depends on the nature of the test agent, the vulnerability of the study population, the length of the study, or the number of sites conducting the clinical study.

Attend this Webinar to learn how the key to their function is as an unblinded oversight group that is independent, confidence and an absolute absence of any Conflicts of Interest.The FDA has increasingly recommended and sometimes mandated that a DMC be involved to advise the sponsor regarding subject safety. The "Stopping Rules" are an important element in a DMC function. Learn why the overriding reasons for a carefully selected (no Conflict of Interest) unblinded, independent, statistician controlled DMC is to promote and guarantee human subject safety as well as data integrity.

Areas Covered in the Webinar:

  • The historical background of why Data and Safety monitoring is essential.
  • The purpose of the Data and Safety monitoring plan.
  • The Regulatory requirements for safety monitoring.
  • Studies requiring a formal Safety Monitoring Committees.
  • What does the "Charter" of a DMC compose of?
  • What is the composition and function of a DMC?
  • What types of studies "require" a DMC?
  • Conflict of interest and the DMC

Who Will Benefit:

This Webinar will provide invaluable assistance to industry study sponsors and those involved in setting up DMCs regarding the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects. Those benefiting the most would be
  • Principal Investigators / Sub-investigators.
  • Clinical Research Scientists (PKs, Biostatisticians,)
  • Safety Nurses.
  • Clinical Research Associates (CRAs) and Coordinators (CRCs).
  • Recruiting staff
  • QA / QC auditors and staff.
  • Clinical Research Data managers

Instructor Profile:

Charles H. Pierce, MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message (via webinars, lectures and seminars) of Risk Management through knowledge of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. Dr. Pierce serves as an advisor to several clinical research organizations. He has been in the Clinical Research Industry for 20+ years, has been involved in developing Phase I & IIa Clinical Pharmacology Units, Investigator and staff GCP training, and medical monitoring in both drug and device studies.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed